IDSA GUIDELINES Bundle (free trial)

Ventriculitis and Meningitis

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/810891

Contents of this Issue

Navigation

Page 8 of 15

9 Patient Monitoring ➤ Patients with healthcare-associated ventriculitis and meningitis should be monitored for response to treatment based on clinical parameters (S-L). ➤ In patients with healthcare-associated ventriculitis and meningitis and an external drainage device, monitoring of CSF cultures is recommended to ensure that they become negative (S-L). ➤ In patients with no definitive clinical improvement, additional CSF analysis is recommended to ensure that the CSF parameters have improved and the cultures become negative (S-L). ➤ For external CSF drains not being used in the treatment of CSF shunt infection, daily CSF cultures and analysis are NOT recommended unless clinically indicated (S-L). Shunt Reimplantion ➤ In patients with infection caused by coagulase-negative staphylococci or P. acnes, with no associated CSF abnormalities and with negative CSF cultures for 48 hours after externalization, a new shunt should be reimplanted as soon as the third day after removal (S-L). ➤ In patients with infection caused by a coagulase-negative Staphylococcus or P. acnes, and associated CSF abnormalities but negative repeat CSF cultures, a new shunt should be reimplanted after 7 days of antimicrobial therapy (S-L). If repeat cultures are positive, antimicrobial treatment is recommended until CSF cultures remain negative for 7–10 consecutive days before a new shunt is placed (S-L). ➤ In patients with infection caused by S. aureus or gram-negative bacilli, a new shunt should be reimplanted 10 days after CSF cultures are negative (S-L). ➤ A period off antimicrobial therapy is NOT recommended to verify clearing of the infection before shunt reimplantation (S-L). S, strong ; W, weak — strength of recommendation H, high; M, moderate; L, low; VL, very low — quality of evidence

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Ventriculitis and Meningitis